Other recent work has suggested that ubiquitin-specific protease 2 (USP2), which is upregulated in intestinal myeloid cells during IBD and mouse models of colitis, increases the expression of collagen and alpha smooth muscle actin (αSMA), leading to further ECM remodeling and tissue stiffening (An et al, 2022). This evidence concerns the gene USP2 and colitis.